Your browser is no longer supported. Please, upgrade your browser.
CFMS Conformis, Inc. daily Stock Chart
Conformis, Inc.
Index- P/E- EPS (ttm)-0.34 Insider Own3.20% Shs Outstand71.23M Perf Week-1.46%
Market Cap55.26M Forward P/E- EPS next Y-0.34 Insider Trans-4.89% Shs Float63.58M Perf Month-7.25%
Income-23.10M PEG- EPS next Q-0.09 Inst Own30.70% Short Float0.84% Perf Quarter-5.38%
Sales72.00M P/S0.77 EPS this Y39.70% Inst Trans32.89% Short Ratio1.42 Perf Half Y-35.27%
Book/sh0.26 P/B2.46 EPS next Y2.90% ROA-32.60% Target Price- Perf Year-65.96%
Cash/sh- P/C- EPS next 5Y-14.58% ROE-174.00% 52W Range0.50 - 1.91 Perf YTD-57.33%
Dividend- P/FCF- EPS past 5Y17.60% ROI-70.10% 52W High-66.58% Beta1.70
Dividend %- Quick Ratio1.50 Sales past 5Y10.00% Gross Margin49.40% 52W Low27.92% ATR0.04
Employees262 Current Ratio1.90 Sales Q/Q-6.90% Oper. Margin-32.20% RSI (14)35.02 Volatility4.71% 6.11%
OptionableNo Debt/Eq0.00 EPS Q/Q35.40% Profit Margin-32.10% Rel Volume1.16 Prev Close0.62
ShortableYes LT Debt/Eq1.32 EarningsNov 04 AMC Payout- Avg Volume375.64K Price0.64
Recom2.00 SMA20-2.77% SMA50-13.14% SMA200-18.01% Volume434,609 Change3.56%
Aug-01-19Downgrade BTIG Research Buy → Neutral
Jan-02-18Downgrade JP Morgan Neutral → Underweight
Dec-20-17Upgrade BTIG Research Neutral → Buy
Aug-04-17Downgrade Deutsche Bank Buy → Hold $6 → $5
Jun-21-17Initiated BTIG Research Neutral
Feb-16-17Downgrade Canaccord Genuity Buy → Hold $12 → $7
Sep-19-16Initiated SunTrust Buy
May-13-16Reiterated Deutsche Bank Buy $26 → $12
May-13-16Downgrade Wells Fargo Outperform → Market Perform
May-13-16Downgrade JP Morgan Overweight → Neutral $18 → $8
Dec-08-15Reiterated Canaccord Genuity Buy $22 → $26
Dec-01-15Initiated Sterne Agee CRT Buy
Aug-12-15Reiterated Oppenheimer Outperform $26 → $27
Jul-27-15Initiated Wells Fargo Outperform
Jul-27-15Initiated Oppenheimer Outperform $26
Jul-27-15Initiated JP Morgan Overweight $28
Jul-27-15Initiated Deutsche Bank Buy $27
Jul-27-15Initiated Canaccord Genuity Buy $27
Nov-24-20 04:30PM  
Nov-09-20 04:30PM  
Nov-07-20 08:19AM  
Nov-04-20 07:35PM  
Nov-03-20 10:09AM  
Oct-28-20 06:30PM  
Oct-06-20 07:30AM  
Sep-29-20 10:45AM  
Sep-24-20 07:00AM  
Sep-16-20 04:30PM  
Sep-08-20 04:30PM  
Sep-02-20 05:30PM  
Aug-20-20 07:30AM  
Aug-13-20 05:15PM  
Aug-10-20 09:25AM  
Aug-05-20 08:45PM  
Jul-23-20 05:00PM  
Jul-22-20 12:32PM  
Jul-08-20 07:00AM  
Jul-06-20 07:30AM  
Jun-24-20 09:50AM  
Jun-22-20 07:38AM  
Jun-21-20 03:46PM  
Jun-15-20 08:19PM  
May-28-20 07:30AM  
May-21-20 08:00AM  
May-11-20 07:25PM  
May-05-20 06:15PM  
Apr-29-20 12:33PM  
Apr-23-20 07:01PM  
Apr-20-20 09:00AM  
Apr-09-20 04:45PM  
Mar-25-20 09:33AM  
Mar-24-20 09:47AM  
Mar-23-20 07:44AM  
Mar-20-20 07:42PM  
Mar-11-20 09:05AM  
Mar-02-20 07:05PM  
Feb-28-20 09:35AM  
Feb-21-20 08:52AM  
Feb-20-20 04:52PM  
Feb-19-20 04:44PM  
Feb-05-20 07:45AM  
Jan-30-20 07:00AM  
Jan-14-20 07:15AM  
Dec-30-19 02:18PM  
Dec-16-19 06:00AM  
Nov-27-19 12:15PM  
Nov-07-19 04:45PM  
Nov-06-19 12:19PM  
Nov-05-19 01:34PM  
Oct-31-19 08:07AM  
Oct-30-19 07:15PM  
Oct-23-19 10:33AM  
Oct-15-19 04:15PM  
Oct-04-19 08:30AM  
Oct-02-19 08:47AM  
Oct-01-19 08:00AM  
Sep-25-19 11:23AM  
Aug-07-19 02:45PM  
Aug-06-19 10:00AM  
Aug-01-19 06:00PM  
Jul-31-19 07:55PM  
Jul-24-19 10:32AM  
Jul-15-19 04:30PM  
Jun-28-19 09:50AM  
Jun-25-19 04:15PM  
Jun-12-19 11:30AM  
May-17-19 11:09AM  
May-06-19 11:41AM  
May-01-19 07:55PM  
Apr-25-19 10:39AM  
Apr-24-19 10:33AM  
Apr-23-19 12:05PM  
Apr-17-19 04:30PM  
Mar-18-19 02:30PM  
Mar-15-19 04:05PM  
Mar-13-19 08:30AM  
Feb-22-19 08:25AM  
Feb-19-19 10:00AM  
Feb-18-19 08:30AM  
Feb-08-19 02:53PM  
Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers personalized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a personalized bicompartmental knee replacement system; and iUni, a personalized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee. It also provides Conformis Hip System, a hip replacement product; and iJigs, a customized single-use patient-specific instrumentation. The company markets and sells its products to hospitals and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore, Hong Kong, Malaysia, Monaco, Hungary, Spain, and Australia. Conformis, Inc. was founded in 2004 and is headquartered in Billerica, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Augusti Mark APresident & CEONov 03Sale0.6640,00026,4602,347,070Nov 04 08:36 PM
Augusti Mark APresident & CEONov 02Sale0.6564,06541,8472,387,070Nov 04 08:36 PM
Augusti Mark APresident & CEOAug 10Sale0.707,9275,5492,451,135Aug 12 06:14 PM
ALLDREDGE J BRENTCLO & SECRETARYJul 29Sale0.783,8523,018424,065Jul 31 05:51 PM
Augusti Mark APresident & CEOJul 02Sale0.7526,28019,7552,459,062Jul 02 07:59 PM
Augusti Mark APresident & CEOMay 15Sale0.957,2946,9292,485,342May 18 06:21 PM
Augusti Mark APresident & CEOMay 07Sale0.9526,18724,8781,799,303May 08 05:47 PM
HENRY ERINCORP CONTROLLER & INTERIM PAOFeb 03Sale1.0016716767,504Feb 05 05:32 PM
HENRY ERINCORP CONTROLLER & INTERIM PAOJan 03Sale1.423,2044,55267,671Jan 06 05:50 PM
Augusti Mark APresident & CEOJan 03Sale1.4256,69980,3371,825,490Jan 06 05:44 PM
Augusti Mark APresident & CEODec 02Sale1.863,3536,2371,882,189Dec 04 07:42 AM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 All Rights Reserved.